Genotype-specific differences in short QT syndrome include variations in cardiac event timing and ECG features, with potassium channel blockers holding potential as a therapeutic strategy
Event:
ESC Congress 2025
Topic:
Ion Channel Disorders
Session:
Arrhythmias: general
